Kazi Mahmood

Kazi Mahmood

Journalist since the 1980's, worked for the BBC Radio in Africa and now owns two news portals. WF is my passion too and it is about humanity and why we should stop wars.
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
Antigene Corporation

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced dosing in Australia of the first subject in the Phase I PROBE
3 min read